Human immune response to HIV-1 Nef .2. Induction of HIV-1/HIV-2 Nef cross-reactive cytotoxic T lymphocytes in peripheral blood lymphocytes of non-infected healthy individuals

被引:11
作者
LucchiariHartz, M
Bauer, M
Niedermann, G
Maier, B
Meyerhans, A
Eichmann, K
机构
[1] MAX PLANCK INST IMMUNBIOL, D-79108 FREIBURG, GERMANY
[2] UNIV FREIBURG, INST MIKROBIOL & HYG, ABT VIROL, D-79104 FREIBURG, GERMANY
基金
巴西圣保罗研究基金会;
关键词
cytotoxic T lymphocytes; HIV-1; HIV-2; HIV Nef; human;
D O I
10.1093/intimm/8.4.577
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-specific CD8(+) cytotoxic T lymphocytes (CTL) are thought to have a beneficial role in HIV infection. In a previous report we have shown that HIV-1 Nef-specific CTL can be readily induced in peripheral blood lymphocytes of seronegative healthy young adults by in vitro stimulation with autologous Epstein-Barr virus-transformed a lymphoblastoid cell lines transfected with the HIV-1 nef gene. Here we demonstrate that these Nef-specific CTL can efficiently lyse HIV-infected primary CD4(+) T lymphocytes. CTL of the blood donor tested were Nef-specific and restricted by the autologous MHC class I molecules HLA-A2 and HLA-B7. They recognized HIV-1 Nef in association with both restriction elements but HIV-2 Nef only in association with HLA-B7. The cross-reactivity of the induced effector cells together with the potent immunogenicity of Nef in healthy seronegatives further support the inclusion of Nef as a constituent of HIV vaccines.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 44 条
[1]   IMMUNOGENICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) RECOMBINANT NEF GENE-PRODUCT - MAPPING OF T-CELL AND B-CELL EPITOPES IN IMMUNIZED CHIMPANZEES [J].
BAHRAOUI, E ;
YAGELLO, M ;
BILLAUD, JN ;
SABATIER, JM ;
GUY, B ;
MUCHMORE, E ;
GIRARD, M ;
GLUCKMAN, JC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (09) :1087-1098
[2]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[3]  
BOURGAULT I, 1991, CLIN EXP IMMUNOL, V84, P501
[4]  
BRINCHMANN JE, 1991, J ACQ IMMUN DEF SYND, V4, P480
[5]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[6]   QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE [J].
CARMICHAEL, A ;
JIN, X ;
SISSONS, P ;
BORYSIEWICZ, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :249-256
[7]   MULTIPLE SUBSETS OF HIV-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T IN HUMANS AND IN MICE [J].
CHENCINER, N ;
MICHEL, F ;
DADAGLIO, G ;
LANGLADEDEMOYEN, P ;
HOFFENBACH, A ;
LEROUX, A ;
GARCIAPONS, F ;
RAUTMANN, G ;
GUY, B ;
GUILLON, JM ;
MAYAUD, C ;
GIRARD, M ;
AUTRAN, B ;
KIENY, MP ;
PLATA, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (09) :1537-1544
[8]   IMPAIRED CYTOTOXIC T-LYMPHOCYTE RECOGNITION DUE TO GENETIC VARIATIONS IN THE MAIN IMMUNOGENIC REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS-1 NEF PROTEIN [J].
COUILLIN, I ;
CULMANNPENCIOLELLI, B ;
GOMARD, E ;
CHOPPIN, J ;
LEVY, JP ;
GUILLET, JG ;
SARAGOSTI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :1129-1134
[9]   IDENTIFICATION OF MULTIRESTRICTED IMMUNODOMINANT REGIONS RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN [J].
CULMANNPENCIOLELLI, B ;
LAMHAMEDICHERRADI, S ;
COUILLIN, I ;
GUEGAN, N ;
LEVY, JP ;
GUILLET, JG ;
GOMARD, E .
JOURNAL OF VIROLOGY, 1994, 68 (11) :7336-7343
[10]   EVOLUTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF AND LONG TERMINAL REPEAT SEQUENCES OVER 4 YEARS INVIVO AND INVITRO [J].
DELASSUS, S ;
CHEYNIER, R ;
WAINHOBSON, S .
JOURNAL OF VIROLOGY, 1991, 65 (01) :225-231